5 completed. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Completed 5 |
Follow Yellow Fever: new trials by email Literature Review of Yellow Fever trials Research Report on Yellow Fever
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Non- Inferiority Fractional-doses Trial for Yellow Fever Vaccine Yellow fever vaccine, Institut Pasteur - Yellow Fever | Phase 4 | Completed | University of Oxford | 900 | 2019-11-11 | 2024-02-09 |
| Turnover of Antigen Specific Lymphocytes and Monocytes After Immunization With the 17D Yellow Fever Vaccine Yellow fever vaccine, Deuterium (70% enriched 2H2O) labeled water - Yellow Fever | Phase 4 | Completed | Sri Edupuganti | 27 | 2019-04-15 | 2025-04-29 |
| Immunogenicity of Fractional One-fifth and One-half Doses of Yellow Fever Vaccine Compared to Full Dose in Children 9-23 Months Old Yellow Fever 17DD Vaccine - Yellow Fever | Phase 4 | Completed | Centers for Disease Control and Prevention | 1788 | 2018-11-01 | 2025-04-08 |
| Immunogenicity and Safety of Fractional Doses of Yellow Fever Vaccines (YEFE) Stamaril, Sanofi Pasteur, Yellow fever vaccine, Bio-Manguinhos, Yellow fever vaccine, Institut Pasteur - Yellow Fever | Phase 4 | Completed | Epicentre | 1630 | 2017-11-06 | 2022-02-01 |
| Human Immune Responses to Yellow Fever Vaccination Yellow Fever Vaccine, Leukapheresis, Fine-needle aspiration (FNA) - Yellow Fever | Phase 4 | Completed | Emory University | 239 | 2008-05-01 | 2025-10-03 |
Arbovirus Infections (5) · Flaviviridae Infections (5) · Flavivirus Infections (5) · Hemorrhagic Fevers, Viral (5) · Infections (5) · Mosquito-Borne Diseases (5) · RNA Virus Infections (5) · Vector Borne Diseases (5) · Virus Diseases (5)
Yellow Fever Vaccine (4) · Biopsy, Fine-Needle (1) · Deuterium (1) · Leukapheresis (1) · Seroconversion (1)
Centers for Disease Control and Prevention (1) · Emory University (1) · Epicentre (1) · Sri Edupuganti (1) · University of Oxford (1)
United States (3) · Kenya (2) · Uganda (2)
Philip Bejon, PhD (1) · Rafi Ahmed, PhD (1) · Sri Edupuganti, MD (1) · Sri Edupuganti, MD, MPH (1)
PMID 31984244, PMID 19933869, PMID 33422245, PMID 37127045, PMID 37127047, PMID 39970397, PMID 41512502, PMID 41544642, PMID 42463194, PMID 42727590
U19AI057266 (2)